glp-1 obesity news World Health Organization recommends drugs for GLP-1 Antagonists Increase Plan Drug

An observational study in Neurology found that GLP1 diabetes drugs were associated with a lower risk of developing epilepsy compared with DPP4 inhibitors

The health agency says it has found retailers in Canada selling unauthorized GLP-1 products sometimes referred to as "fauxzempic" both in stores and online.

Explore Ozempic for Effective Medical Weight Loss at Universal Weight Loss Clinic in Bakersfield, CA

University of Cincinnati researchers, funded by the NIH, are studying how GLP-1 drugs may help prevent Alzheimers disease by analyzing real-world data from patients with mild cognitive impairment

Ozempic dosing begins low and increases gradually over 4 months to maximize weight loss while minimizing side effects

Results In total, 9795 patients in the GLP-1 RAs group (302 with HF